Drugs Controller General of India (DCGI)

Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine

Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine

New Delhi: The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting th...Read More

FPJ Exclusive: Both Covishield and Covaxin are safe, says Dr Shashank Joshi, Maharashtra Covid-19 task force member

FPJ Exclusive: Both Covishield and Covaxin are safe, says Dr Shashank Joshi, Maharashtra Covid-19 task force member

Mumbai: In an exclusive interview with The Free Press Journal, Dr Shashank Joshi, member of the state's Covid-19 task force explains the ...Read More

Will COVID-19 vaccine make you impotent? Here's what DCGI VG Somani has to say

Will COVID-19 vaccine make you impotent? Here's what DCGI VG Somani has to say

New Delhi: As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelle...Read More

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

COVID-19: Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.

Submit previous trial data for Covaxin before rolling out phase III: DCGI to Bharat Biotech

Submit previous trial data for Covaxin before rolling out phase III: DCGI to Bharat Biotech

New Delhi: Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been...Read More

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

New Delhi: Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinic...Read More

Coronavirus in Maharashtra: State govt to procure Itolizumab to treat moderate to severe cases

Coronavirus in Maharashtra: State govt to procure Itolizumab to treat moderate to severe cases

The Maharashtra government, which is struggling to curb the COVID-19 pandemic, has decided to procure Itolizumab (a monoclonal antibody) ...Read More

DCGI gives nod for 'restricted emergency use' of Itolizumab for moderate to severe COVID-19 patients

DCGI gives nod for 'restricted emergency use' of Itolizumab for moderate to severe COVID-19 patients

Mumbai: Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been gran...Read More

Market Update: Rupee jumps 44 paise to 74.60 against US dollar in early trade

Market Update: Rupee jumps 44 paise to 74.60 against US dollar in early trade

Mumbai: The rupee appreciated 44 paise to 74.60 against the US dollar in early trade on Friday tracking weakness in the greenback and gai...Read More

Free Press Journal

www.freepressjournal.in